| Name: | ACURA PHARMACEUTICALS, INC. |
| Jurisdiction: | New York |
| Legal type: | DOMESTIC BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 10 Apr 1935 (90 years ago) |
| Entity Number: | 48416 |
| ZIP code: | 10005 |
| County: | New York |
| Place of Formation: | New York |
| Principal Address: | 616 N NORTH COURT, SUITE 120, PALATINE, IL, United States, 60067 |
| Address: | 28 LIBERTY ST., NEW YORK, NY, United States, 10005 |
Shares Details
Shares issued 300
Share Par Value 0
Type NO PAR VALUE
| Name | Role | Address |
|---|---|---|
| ROBERT JONES | Chief Executive Officer | 616 N NORTH COURT, SUITE 120, PALATINE, IL, United States, 60067 |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | Agent | 28 LIBERTY ST., NEW YORK, NY, 10005 |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | DOS Process Agent | 28 LIBERTY ST., NEW YORK, NY, United States, 10005 |
A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.
Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a
government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity
doing business with the federal government must register for a UEI.
A CIK (Central Index Key) number is a unique identifier assigned by the U.S. Securities and Exchange Commission (SEC) to companies that: Are publicly
traded on U.S. stock exchanges, File reports with the SEC.
Note: Having a CIK number indicates that: The company is registered with the SEC, Files regular financial reports (like 10-K, 10-Q), Must
comply with federal securities laws and regulations, Has public shareholders, Makes financial information publicly available through SEC's EDGAR
database.
| Start date | End date | Type | Value |
|---|---|---|---|
| 2025-04-16 | 2025-04-16 | Address | 616 N NORTH COURT, SUITE 120, PALATINE, IL, 60067, USA (Type of address: Chief Executive Officer) |
| 2024-03-26 | 2025-04-16 | Address | 616 N NORTH COURT, SUITE 120, PALATINE, IL, 60067, USA (Type of address: Chief Executive Officer) |
| 2024-03-26 | 2024-03-26 | Address | 616 N NORTH COURT, SUITE 120, PALATINE, IL, 60067, USA (Type of address: Chief Executive Officer) |
| 2024-03-26 | 2025-04-16 | Shares | Share type: PAR VALUE, Number of shares: 100000000, Par value: 0.01 |
| 2024-03-26 | 2025-04-16 | Address | 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Registered Agent) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 250416003682 | 2025-04-16 | BIENNIAL STATEMENT | 2025-04-16 |
| 240326003530 | 2024-03-26 | BIENNIAL STATEMENT | 2024-03-26 |
| 210406061018 | 2021-04-06 | BIENNIAL STATEMENT | 2021-04-01 |
| 190411061413 | 2019-04-11 | BIENNIAL STATEMENT | 2019-04-01 |
| SR-767 | 2019-01-28 | CERTIFICATE OF CHANGE (BY AGENT) | 2019-01-28 |
Date of last update: 19 Mar 2025
Sources: New York Secretary of State
